AKT1 and skeletal muscle disorder: Some investigators reported that AET reduces microRNA‐1 levels and increases PI3K/AKT/mTOR pathways in healthy people.47 A different scenario was observed in patients with skeletal myopathy associated with chronic HFrEF.